Medication outlays top 5.29 trillion won in 2012

Published: 2013-10-15 07:00:00

Updated: 2013-10-15 07:00:00

The medication costs claimed by Korea’s 69 drug firms came to 5.29 trillion won in 2012, down 6.84 percent from a year earlier, data showed Sunday.

According to the Health Insurance Review and Assessment Service (HIRA), the combined drug outlays claimed by the 69 firms amounted to 3.86 trillio...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK